SEC to investigate leaks to investors of medical research results

[JURIST] The US Securities and Exchange Commission [official website] is examining whether investors paid researchers to reveal information about ongoing drug studies in order to profit from the results before they were available to the public. Earlier this month, The Seattle Times [newspaper website] said it found 26 cases [ST report] in which medical researchers "leaked confidential and critical details" to brokerage firms and hedge funds for profit. "The latest revelations have been added to the ongoing review of possible insider trading involving potential blockbuster drugs in advance of FDA decisions," an SEC official said. The FDA will assist the SEC in its investigation under an interagency cooperation agreement. Reuters has more.



 

About Paper Chase

Paper Chase is JURIST's real-time legal news service, powered by a team of 30 law student reporters and editors led by law professor Bernard Hibbitts at the University of Pittsburgh School of Law. As an educational service, Paper Chase is dedicated to presenting important legal news and materials rapidly, objectively and intelligibly in an accessible format.

© Copyright JURIST Legal News and Research Services, Inc., 2013.